New York, NY, United States of America

Wayne P Rothbaum

This inventor holds 2 USPTO granted patents. Top assignee: Iovance Biotherapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wayne P Rothbaum. Retrieved from https://idiyas.com/inventor/wayne-p-rothbaum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wayne P Rothbaum: Innovator in T-Cell Therapy

Introduction

Wayne P Rothbaum is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cell therapy, particularly in the area of T-cell potency assays. With a total of 2 patents, Rothbaum's work is paving the way for advancements in therapeutic applications.

Latest Patents

Rothbaum's latest patents include "Methods and Compositions for T-Cell Coculture Potency Assays and Use with Cell Therapy Products." This innovative approach aims to enhance the effectiveness of cell therapy products by improving the assessment of T-cell potency.

Career Highlights

Wayne P Rothbaum is currently associated with Iovance Biotherapeutics, Inc., where he continues to push the boundaries of research and development in cell therapy. His expertise and dedication to innovation have positioned him as a key figure in the industry.

Collaborations

Rothbaum collaborates with esteemed colleagues such as Michelle R Simpson-Abelson and Matthew J Frigault. Their combined efforts contribute to the advancement of T-cell therapies and the overall progress in the field.

Conclusion

Wayne P Rothbaum's contributions to T-cell therapy and his innovative patents highlight his role as a leading inventor in the biotechnology sector. His work continues to inspire advancements that may significantly impact patient care in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…